Hyprevention Raises Funds to Support V-STRUT Vertebral Implant

Hyprevention raised USD $4.5 million to support U.S. commercialization of the V-STRUT© Vertebral Implant. Postmarket clinical studies will be conducted to continuously show the high performance of the products to address real clinical needs.

The company has developed the STRUTPLASTY® Platform intended to reinforce bone in case of fractures or...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us